JNJ-42165279
Overview[edit | edit source]
JNJ-42165279 is a chemical compound that has been studied for its potential therapeutic effects in various neurological conditions. It is known to act as an inhibitor of the enzyme fatty acid amide hydrolase (FAAH), which is involved in the degradation of endocannabinoids such as anandamide. By inhibiting FAAH, JNJ-42165279 increases the levels of endocannabinoids, which can modulate pain, mood, and other physiological processes.
Mechanism of Action[edit | edit source]
JNJ-42165279 functions primarily as a selective inhibitor of FAAH. FAAH is an enzyme that breaks down fatty acid amides, including anandamide, a key endocannabinoid. By inhibiting FAAH, JNJ-42165279 prevents the breakdown of anandamide, leading to increased levels of this compound in the brain and other tissues. This elevation in anandamide levels can enhance the activation of cannabinoid receptors, particularly CB1 and CB2 receptors, which are involved in modulating pain, inflammation, and mood.
Potential Therapeutic Applications[edit | edit source]
The inhibition of FAAH by JNJ-42165279 has been explored for its potential benefits in treating various conditions, including:
- Chronic Pain: By increasing endocannabinoid levels, JNJ-42165279 may help alleviate chronic pain conditions by modulating pain pathways in the central nervous system.
- Anxiety Disorders: The anxiolytic effects of elevated anandamide levels could be beneficial in reducing symptoms of anxiety.
- Depression: Modulation of the endocannabinoid system has been suggested to have antidepressant effects, making JNJ-42165279 a potential candidate for depression treatment.
Research and Development[edit | edit source]
Research on JNJ-42165279 has primarily been conducted in preclinical and early clinical settings. Studies have focused on its pharmacokinetics, safety profile, and efficacy in animal models of pain and anxiety. However, further research is needed to fully understand its therapeutic potential and safety in humans.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
